The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Antiphospholipid syndrome

Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 864 · see citing works

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies

Lockshin, M. D., Kim, M., Laskin, C. A., Guerra, M., Branch, D. W., Merrill, J., Petri, M., Porter, T. F., Sammaritano, L., Stephenson, M. D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34402 · Cited by 388 · see citing works

14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Erkan, D., Aguiar, C. L., ANDRADE, D. C. O. D., Cohen, H., Cuadrado, M. J., Danowski, A., Levy, R. A., Ortel, T. L., Rahman, A., Salmon, J. E., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.053 · Cited by 317 · see citing works

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

Alijotas‐Reig, J., Esteve‐Valverde, E., Ferrer‐Oliveras, R., Comet, L. S., Lefkou, E. E., MEKINIAN, A., Belizna, C. C., Ruffatti, A., Tincani, A., Marozio, L., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.12.006 · Cited by 215 · see citing works

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study

Ruffatti, A., Tonello, M., Visentin, M. S., Bontadi, A., Hoxha, A., Carolis, S. D., Botta, A., Salvi, S., Nuzzo, M. D., Rovere, P. Q., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/ker139 · Cited by 214 · see citing works

Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome

Bramham, K., Hunt, B., Germain, S., Calatayud, I., Khamashta, M., Bewley, S., & Nelson-Piercy, C. (2010) · Lupus · doi:10.1177/0961203309347794 · Cited by 185 · see citing works

First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss

Bramham, K., Thomas, M., Nelson-Piercy, C., Khamashta, M., & Hunt, B. J. (2011) · Blood · doi:10.1182/blood-2011-02-339234 · Cited by 180 · see citing works

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases

Alijotas‐Reig, J., Ferrer‐Oliveras, R., Ruffatti, A., Tincani, A., Lefkou, E. E., Bertero, M. T., Coloma, E., Carolis, S. D., Espinosa, G., Rovere, P. Q., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.010 · Cited by 152 · see citing works

Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients

Schmidt‐Tanguy, A., Voswinkel, J., Henrion, D., Subra, J. F., Loufrani, L., Rohmer, V., Ifrah, N., & Belizna, C. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12363 · Cited by 132 · see citing works

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome

Ruffatti, A., Calligaro, A., Hoxha, A., Trevisanuto, D., Ruffatti, A., Gervasi, M. T., Cuffaro, S., Pengo, V., & Punzi, L. (2010) · Arthritis Care & Research · doi:10.1002/acr.20098 · Cited by 114 · see citing works

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity: A European multicentre retrospective study

Salvan, E., Ross, T. D., Gerosa, M., Andreoli, L., Maina, A., Alijotas-Reig, J., Carolis, S. D., Mekinian, A., Bertero, M. T., Canti, V., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0191 · Cited by 108 · see citing works

European registry of babies born to mothers with antiphospholipid syndrome

MEKINIAN, A., Lachassinne, E., Nicaise‐Roland, P., Carbillon, L., Motta, M., Vicaut, É., Boinot, C., Avčin, T., Toumelin, P. L., Carolis, S. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201167 · Cited by 105 · see citing works

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

Marchetti, T., Ruffatti, A., Wuillemin, C., de Moerloose, P., & Cohen, M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12570 · Cited by 91 · see citing works

Effect of Hydroxychloroquine on Antiphospholipid Antibody‐Induced Changes in First Trimester Trophoblast Function

Albert, C. R., Schlesinger, W. J., Viall, C. A., Mulla, M. J., Brosens, J. J., Chamley, L., & Abrahams, V. M. (2013) · American Journal of Reproductive Immunology · doi:10.1111/aji.12184 · Cited by 87 · see citing works

Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression

Wu, X.-X., Guller, S. M., & Rand, J. H. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.064 · Cited by 84 · see citing works

Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?

MEKINIAN, A., Costedoat-Chalumeau, N., MASSEAU, A., Tincani, A., Caroli, S. D., Alijotas‐Reig, J., Ruffatti, A., Ambrožič, A., Botta, A., Guern, V. L., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.040 · Cited by 73 · see citing works

Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management

Alijotas‐Reig, J. (2012) · Lupus · doi:10.1177/0961203312465782 · Cited by 69 · see citing works

Antiphospholipid syndrome: From pathogenesis to novel immunomodulatory therapies

Comarmond, C., & Cacoub, P. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.006 · Cited by 69 · see citing works

Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature

Ruffatti, A., Marson, P., Pengo, V., Favarò, M., Tonello, M., Bortolati, M., Minucci, D., & Silvestro, G. D. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.11.002 · Cited by 66 · see citing works

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A preliminary first year report

Alijotas‐Reig, J., & Ferrer‐Oliveras, R. (2012) · Lupus · doi:10.1177/0961203312440058 · Cited by 64 · see citing works

APS ACTION – AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking

Erkan, D., & Lockshin, M. (2012) · Lupus · doi:10.1177/0961203312437810 · Cited by 61 · see citing works

EULAR recommendations for the management of antiphospholipid syndrome in adults

Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,261 · see citing works

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

Andréoli, L., Bertsias, G. K., Agmon‐Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer‐Betz, R., Förger, F., Moraes‐Fontes, M. F., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 946 · see citing works

Antiphospholipid syndrome

Schreiber, K. I., Sciascia, S., de Groot, P. G., Devreese, K. M. J., Jacobsen, S., Ruiz‐Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.103 · Cited by 437 · see citing works

Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review

Plantone, D., & Koudriavtseva, T. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0656-y · Cited by 305 · see citing works

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

Russell, M., Dey, M., Flint, J., Davie, P., Allen, A., Crossley, A., Frishman, M., Gayed, M., Hodson, K. K., Khamashta, M. A., et al. (2022) · Lara D. Veeken · doi:10.1093/rheumatology/keac551 · Cited by 237 · see citing works

The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies

Sciascia, S., Hunt, B. J., Talavera-García, E., Lliso-Ribera, G., Khamashta, M. A., & Cuadrado, M. J. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.09.078 · Cited by 201 · see citing works

Antiphospholipid syndrome

Sammaritano, L. R. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.101463 · Cited by 201 · see citing works

Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?

MEKINIAN, A., Cohen, J., Alijotas‐Reig, J., Carbillon, L., Nicaise‐Roland, P., Kayem, G., Daraï, É., Fain, O., & Bornes, M. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12493 · Cited by 176 · see citing works

Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy

Petri, M., Elkhalifa, M., Li, J., Magder, L. S., & Goldman, D. W. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41121 · Cited by 143 · see citing works

Female Infertility and Serum Auto-antibodies: a Systematic Review

Deroux, A., Dumestre‐Pérard, C., Dunand-Faure, C., Bouillet, L., & Hoffmann, P. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8586-z · Cited by 136 · see citing works

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies

Schreiber, K. I., Breen, K. A., Cohen, H., Jacobsen, S., Middeldorp, S., Pavord, S. R., Regan, L., Roccatello, D., Robinson, S. E., Sciascia, S., et al. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1603359 · Cited by 128 · see citing works

Pathogenesis and management of antiphospholipid syndrome

Arachchillage, D. J., & Laffan, M. (2017) · British Journal of Haematology · doi:10.1111/bjh.14632 · Cited by 120 · see citing works

Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome

Bertolaccini, M. L., Contento, G., Lennen, R. J., Sanna, G., Blower, P. J., Ma, M., Sunassee, K., & Girardi, G. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.008 · Cited by 105 · see citing works

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults

Tektonidou, M. G., Andréoli, L., Limper, M., Tincani, A., & Ward, M. M. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000924 · Cited by 99 · see citing works

Managing antiphospholipid syndrome in pregnancy

Schreiber, K. I., & Hunt, B. J. (2019) · Thrombosis Research · doi:10.1016/s0049-3848(19)30366-4 · Cited by 96 · see citing works

The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases

Martinez, G. P., Zabaleta, M. E., Giulio, C. D., Charris, J., & Mijares, M. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200707132920 · Cited by 95 · see citing works

Immunomodulators in SLE: Clinical evidence and immunologic actions

Durcan, L., & Petri, M. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.010 · Cited by 92 · see citing works

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study

Tonello, M., Hoxha, A., Sciascia, S., Cuadrado, M. J., Latino, J. O., Udry, S., Reshetnyak, T. M., Costedoat-Chalumeau, N., Morel, N., Marozio, L., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1632388 · Cited by 89 · see citing works

Antiphospholipid syndrome – an update

Linnemann, B. (2018) · VASA · doi:10.1024/0301-1526/a000723 · Cited by 85 · see citing works

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome

Belizna, C. C., Pregnolato, F., Abad, S., Alijotas‐Reig, J., Amital, H., Amoura, Z., Andréoli, L., Andrès, E., Aouba, A., Bilgen, Ş. A., et al. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.05.012 · Cited by 78 · see citing works

The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies

Sciascia, S., Branch, D. W., Levy, R. A., Middeldorp, S., Pavord, S. R., Roccatello, D., Ruiz‐Irastorza, G., Tincani, A., Khamashta, M. A., Schreiber, K. I., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-06-0491 · Cited by 78 · see citing works

Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations

Velásquez, M., Rojas, M., Abrahams, V. M., Escudero, C., & Cadavid, Á. P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01840 · Cited by 81 · see citing works

The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus

Giacomelli, R., Afeltra, A., Bartoloni, E., Berardicurti, O., Bombardieri, M., Bortoluzzi, A., Carubbi, F., Caso, F., Cervera, R., Ciccia, F., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102738 · Cited by 78 · see citing works

EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies

Pregnolato, F., Gerosa, M., Raimondo, M. G., Comerio, C., Bartoli, F., Lonati, P. A., Borghi, M. O., Acaia, B., Ossola, M. W., Ferrazzi, E. M., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa203 · Cited by 76 · see citing works

Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study

MEKINIAN, A., Alijotas‐Reig, J., Carrat, F., Costedoat-Chalumeau, N., Ruffatti, A., Lazzaroni, M. G., Tabacco, S., Maina, A., MASSEAU, A., Morel, N., et al. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.006 · Cited by 75 · see citing works

A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus

Lazzaroni, M. G., Dall’Ara, F., Fredi, M., Nalli, C., Reggia, R., Lojacono, A., Ramazzotto, F., Zatti, S., Andréoli, L., & Tincani, A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.016 · Cited by 69 · see citing works

Delineating the deranged immune system in the antiphospholipid syndrome

van den Hoogen, L. L., van Roon, J. A. G., Radstake, T. R. D. J., Fritsch-Stork, R. D. E., & Derksen, R. H. W. M. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.08.011 · Cited by 66 · see citing works

The treatment of anti-phospholipid syndrome: A comprehensive clinical approach

Chighizola, C. B., Andréoli, L., Gerosa, M., Tincani, A., Ruffatti, A., & Meroni, P. L. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.02.003 · Cited by 66 · see citing works

Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure

Garmendia, J. V., Sanctis, C. V. D., Hajdúch, M., & Sanctis, J. B. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031295 · Cited by 68 · see citing works

Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies

MEKINIAN, A., Bourrienne, M., Carbillon, L., Benbara, A., Abisror, N., Chollet‐Martin, S., Tigaizin, A., Montestruc, F., Fain, O., & Nicaise‐Roland, P. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.05.006 · Cited by 59 · see citing works

An update on the management of antiphospholipid syndrome

Rodziewicz, M., & D’Cruz, D. P. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20910855 · Cited by 59 · see citing works

The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies

Schreiber, K. I., Breen, K. A., Parmar, K., Rand, J. H., Wu, X.-X., & Hunt, B. J. (2017) · Rheumatology · doi:10.1093/rheumatology/kex378 · Cited by 55 · see citing works

Current insights in obstetric antiphospholipid syndrome

Schreiber, K. I., Radin, M., & Sciascia, S. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000406 · Cited by 53 · see citing works

Pregnancy outcomes in patients with primary antiphospholipid syndrome

Liu, L., & Sun, D. (2019) · Medicine · doi:10.1097/md.0000000000015733 · Cited by 53 · see citing works

Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome

Arachchillage, D. J., Laffan, M., & Pericleous, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021331 · Cited by 53 · see citing works

Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies

Fredi, M., Andréoli, L., Aggogeri, E., Bettiga, E., Lazzaroni, M. G., Guern, V. L., Lojacono, A., Morel, N., Piette, J. C., Zatti, S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00864 · Cited by 50 · see citing works

Antiphospholipid syndrome: state of the art on clinical practice guidelines

Limper, M., Scirè, C. A., Talarico, R., Amoura, Z., Avčin, T., Basile, M., Burmester, G. R., Carli, L., Cervera, R., Costedoat-Chalumeau, N., et al. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000785 · Cited by 50 · see citing works

Emerging Therapies in Antiphospholipid Syndrome

ANDRADE, D. C. O. D., & Tektonidou, M. G. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0566-z · Cited by 48 · see citing works

Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications

Xourgia, E., & Tektonidou, M. G. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102311 · Cited by 48 · see citing works

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies

Lazzaroni, M. G., Fredi, M., Andréoli, L., Chighizola, C. B., Ross, T. D., Gerosa, M., Kuzenko, A., Raimondo, M.-G., Lojacono, A., Ramazzotto, F., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01948 · Cited by 50 · see citing works

Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria

Marshall, E., Robertson, M., Kam, S., Penwarden, A., Riga, P., & Davies, N. P. (2020) · Eye · doi:10.1038/s41433-020-1038-2 · Cited by 45 · see citing works

Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases

Alijotas‐Reig, J., Esteve‐Valverde, E., Llurba, E., & Gris, J. M. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.02.006 · Cited by 43 · see citing works

Antiphospholipid syndrome: an update

Merashli, M., Noureldine, M. H. A., Uthman, I. W., & Khamashta, M. A. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12449 · Cited by 43 · see citing works

Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

Carolis, S. D., Botta, A., Salvi, S., di Pasquo, E., Sordo, G. D., Garufi, C., Lanzone, A., & Carolis, M. P. D. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.010 · Cited by 43 · see citing works

Update on the pathogenesis and treatment of the antiphospholipid syndrome

Chighizola, C. B., Raschi, E., Borghi, M. O., & Meroni, P. L. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000200 · Cited by 39 · see citing works

New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis

Casian, A., Sangle, S. R., & D’Cruz, D. P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.016 · Cited by 37 · see citing works

Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era

Colla, L., Diena, D., Rossetti, M. M., Manzione, A. M., Marozio, L., Benedetto, C., & Biancone, L. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0477-3 · Cited by 36 · see citing works

Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies

Nalli, C., Lini, D., Andréoli, L., Crisafulli, F., Fredi, M., Lazzaroni, M. G., Bitsadze, V., Calligaro, A., Canti, V., Caporali, R. F., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9060671 · Cited by 36 · see citing works

Management of Systemic Lupus Erythematosus During Pregnancy

Sammaritano, L. R. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-042915-102658 · Cited by 35 · see citing works

Treatment of antiphospholipid syndrome beyond anticoagulation

Dobrowolski, C., & Erkan, D. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.03.001 · Cited by 35 · see citing works

Use of antimalarial drugs is associated with a lower risk of preeclampsia in lupus pregnancy: A prospective cohort study

Saavedra, M. Á., Miranda-Hernández, D. G., Lara‐Mejía, A., Sánchez, A., Morales, S., Reyes, C. V. C., Cruz-Domínguez, M. P., Medina, G., & Jara, L. J. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13830 · Cited by 34 · see citing works

16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome

de Jesús, G. R., Benson, A. E., Chighizola, C. B., Sciascia, S., & Branch, D. W. (2020) · Lupus · doi:10.1177/0961203320954520 · Cited by 35 · see citing works

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss

Pleguezuelo, D. E., Cabrera-Marante, Ó., Abad, M., Rodriguez-Frias, E. A., Naranjo, L., Vázquez, A. F., Villar, O., Gil‐Etayo, F. J., Serrano, M., Pérez‐Rivilla, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102094 · Cited by 36 · see citing works

Preeclampsia and the Antiphospholipid Syndrome

Mayer-Pickel, K. I., Nanda, M., Gajić, M., & Cervar-Zivkovic, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082298 · Cited by 33 · see citing works

Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study

Pasquier, É., Martin, L. D. S., Marhic, G., Chauleur, C., Bohec, C., Bretelle, F., Lejeune, V., Hannigsberg, J., Plu‐Bureau, G., Cogulet, V., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025649 · Cited by 33 · see citing works

Positive antiphospholipid antibodies: observation or treatment?

Grygiel‐Górniak, B., & Mazurkiewicz, Ł. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02834-6 · Cited by 32 · see citing works

Treatment of antiphospholipid syndrome

Radin, M., Cecchi, I., Rubini, E., Foddai, S. G., Barinotti, A., Menegatti, E., Roccatello, D., & Sciascia, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108597 · Cited by 31 · see citing works

Évaluation du bénéfice de l’utilisation d’hydroxychloroquine pour l’obtention d’une grossesse à terme non compliquée en cas de syndrome des antiphospholipides primaire : étude de phase II multicentrique randomisée en double insu versus placebo, HYDROSAPL

MEKINIAN, A., Vicaut, É., Cohen, J., Bornes, M., Kayem, G., & Fain, O. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.06.008 · Cited by 31 · see citing works

Management of Antiphospholipid Syndrome

Ghembaza, A., & Saadoun, D. (2020) · Biomedicines · doi:10.3390/biomedicines8110508 · Cited by 50 · see citing works

Antiphospholipid syndrome: Diagnosis and management in the obstetric patient

Arslan, E., & Branch, D. W. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.10.001 · Cited by 30 · see citing works

Obstetric antiphospholipid syndrome

Esteve‐Valverde, E., Ferrer‐Oliveras, R., & Alijotas‐Reig, J. (2015) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2015.11.003 · Cited by 29 · see citing works

Pregnancy and reproductive aspects of systemic lupus erythematosus

Andréoli, L., Crisafulli, F., & Tincani, A. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000415 · Cited by 29 · see citing works

Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up

Simonin, L., Pasquier, É., Leroyer, C., Cornec, D., Lemerle, J., Bendaoud, B., Hillion, S., Pers, J., Couturaud, F., & Renaudineau, Y. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8568-1 · Cited by 29 · see citing works

Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review

Hooper, A., Bacal, V., & Bedaiwy, M. A. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13761 · Cited by 28 · see citing works

Dilemmas in the diagnosis and management of antiphospholipid syndrome

Manning, J. E., & Arachchillage, D. J. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.03.027 · Cited by 30 · see citing works

Update on Antiphospholipid Syndrome: Ten Topics in 2017

Cavazzana, I., Andréoli, L., Limper, M. A., Franceschini, F., & Tincani, A. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0718-4 · Cited by 28 · see citing works

Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

Mormile, I., Granata, F., Punziano, A., de Paulis, A., & Rossi, F. W. (2021) · Biomedicines · doi:10.3390/biomedicines9020132 · Cited by 27 · see citing works

Anti‐phospholipid antibodies and reproductive failures

Beltagy, A., Trespìdi, L., Gerosa, M., Ossola, M. W., Meroni, P. L., & Chighizola, C. B. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13258 · Cited by 27 · see citing works

Recognition and management of antiphospholipid syndrome

Gerosa, M., Meroni, P. L., & Erkan, D. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000240 · Cited by 26 · see citing works

Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis

Bundhun, P. K., Soogund, M. Z. S., & Huang, F. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1850-x · Cited by 26 · see citing works

Correction: Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria

Marshall, E., Robertson, M., Kam, S., Penwarden, A., Riga, P., & Davies, N. P. (2020) · Eye · doi:10.1038/s41433-020-1102-y · Cited by 26 · see citing works

Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis

Yang, Z., Shen, X., Zhou, C., Wang, M., Liu, Y., & Zhou, L. (2020) · Lupus · doi:10.1177/0961203320967097 · Cited by 25 · see citing works

The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies

Ruffatti, A., Tonello, M., Favarò, M., Ross, T. D., Calligaro, A., Gervasi, M. T., Gervasi, M. T., & Hoxha, A. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.10.001 · Cited by 25 · see citing works

Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis

Liu, Y., Wei, Y., Zhang, Y., & Yang, H. (2023) · Clinical Rheumatology · doi:10.1007/s10067-022-06496-2 · Cited by 25 · see citing works

Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome—A Retrospective Analysis and a Review of Additional Treatment in Pregnancy

Mayer-Pickel, K. I., Eberhard, K., Lang, U., & Cervar-Zivkovic, M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8569-0 · Cited by 25 · see citing works

Síndrome antifosfolipídico obstétrico

Esteve‐Valverde, E., Ferrer‐Oliveras, R., & Alijotas‐Reig, J. (2015) · Revista Clínica Española · doi:10.1016/j.rce.2015.09.003 · Cited by 23 · see citing works

Antiphospholipid syndrome: an update for clinicians and scientists

Vreede, A. P., Bockenstedt, P. L., & Knight, J. S. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000410 · Cited by 22 · see citing works

Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?

Meroni, P. L. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.07.003 · Cited by 22 · see citing works

Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review

Ruffatti, A., Hoxha, A., Favarò, M., Tonello, M., Colpo, A., Cucchini, U., Banzato, A., & Pengo, V. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8571-6 · Cited by 21 · see citing works

Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?

Andréoli, L., Regola, F., Caproli, A., Crisafulli, F., Fredi, M., Lazzaroni, M. G., Nalli, C., Piantoni, S., Zatti, S., Franceschini, F., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead537 · Cited by 23 · see citing works

Management of pregnant women with antiphospholipid antibodies

Ruffatti, A., Favarò, M., Calligaro, A., Zambon, A., & Ross, T. D. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1565995 · Cited by 21 · see citing works

How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice

Fairley, J. L., Nikpour, M., Mack, H. G., Brosnan, M. J., Saracino, A., Pellegrini, M., & Wicks, I. P. (2022) · Internal Medicine Journal · doi:10.1111/imj.15908 · Cited by 20 · see citing works

Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis

Riancho‐Zarrabeitia, L., López-Marín, L., Muñoz, P., López‐Hoyos, M., del Barrio, R., Haya, A., & Martínez-Taboada, V. M. (2022) · Lupus · doi:10.1177/09612033221091401 · Cited by 18 · see citing works

The pathogenesis of obstetric APS: a 2023 update

Mineo, C., Shaul, P. W., & Bermas, B. L. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109745 · Cited by 23 · see citing works

Obstetric anti-phospholipid syndrome: from pathogenesis to treatment

Kaneko, K., Ozawa, N., & Murashima, A. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1969116 · Cited by 18 · see citing works

Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature

Hoxha, A., Tormene, D., Campello, E., & Simioni, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849692 · Cited by 17 · see citing works

Obstetric Anti-phospholipid Syndrome: State of the Art

Gerardi, M. C., Fernandes, M. A., Tincani, A., & Andréoli, L. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0772-y · Cited by 16 · see citing works

What’s new in obstetric antiphospholipid syndrome

Branch, D. W. (2019) · Hematology · doi:10.1182/hematology.2019000043 · Cited by 16 · see citing works

Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study

Ricard, L., Laurent, C., Papo, M., Deriaz, S., Catano, J., Alamowitch, S., Kayem, G., Chasset, F., MOREUIL, C. D., Boffa, J. J., et al. (2021) · Joint Bone Spine · doi:10.1016/j.jbspin.2021.105297 · Cited by 14 · see citing works

Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China

Zhou, Z., Teng, J., Sun, Y., Liu, H., Cheng, X., Su, Y., Yang, C., & Ye, J. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04670-7 · Cited by 16 · see citing works

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study

Hoxha, A., Favarò, M., Calligaro, A., Ross, T. D., Ruffatti, A. T., Infantolino, C., Tonello, M., Mattia, E., & Ruffatti, A. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1697665 · Cited by 14 · see citing works

Prevention of Pregnancy Complications in Antiphospholipid Syndrome

Czwalinna, A., & Bergmann, F. (2020) · Hämostaseologie · doi:10.1055/a-1113-0689 · Cited by 14 · see citing works

Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Carolis, S. D., Rizzo, F., & Tabacco, S. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.08.113 · Cited by 14 · see citing works

Pregnancy Management in Women with Antiphospholidic Syndrome

Radu, A., Dudu, S. C., Ciobanu, A. M., Peltecu, G. C., Iancu, G., Botezatu, R., Gică, N., & Panaitescu, A. M. (2019) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2019.14.2.148 · Cited by 15 · see citing works

Obstetric antiphospholipid syndrome

Soto-Peleteiro, A., González-Echávarri, C., & Ruiz‐Irastorza, G. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2024.05.001 · Cited by 15 · see citing works

Hydroxychloroquine as a Preventive and Therapeutic Option in Preeclampsia – a Literature Review

Deharde, D., Klockenbusch, W., Schmitz, R., Brand, M., Köster, H. A., & de Murcia, K. O. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1170-5145 · Cited by 13 · see citing works

Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis

Ceccarelli, F., Pirone, C., Perricone, C., Selntigia, A., Orefice, V., Pacucci, V. A., Truglia, S., Spinelli, F. R., Galoppi, P., Alessandri, C., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa470 · Cited by 14 · see citing works

The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: A systematic review and meta-analysis

Tian, Y., Xu, J., Chen, D., Yang, C., & Peng, B. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2021.102121 · Cited by 13 · see citing works

Deciphering the immunological interactions: targeting preeclampsia with Hydroxychloroquine’s biological mechanisms

Gajić, M., Schröder‐Heurich, B., & Mayer-Pickel, K. I. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1298928 · Cited by 14 · see citing works

Obstetric and perinatal outcomes of pregnancy in patients with repeated implantation failure

Chin, T.-H., Hsu, Y. C., Soong, Y. K., Lee, C. L., Wang, H. S., Huang, H. Y., Wu, H. M., Yu, H. T., Huang, S. Y., & Chang, C. L. (2019) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.05.010 · Cited by 12 · see citing works

THU0396 The Efficacy of Hydroxychloroquine for Obstetrical Outcome in Anti-Phospholipid Syndrome: Data from a European Multicenter Retrospective Study

MEKINIAN, A., Lazzaroni, M. G., Kuzenko, A., Alijotas‐Reig, J., Ruffatti, A., Levy, P., Canti, V., Bremme, K., Bézanahary, H., Bertero, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-eular.1716

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome

Gerde, M., Ibarra, E. E. M., Kenzie, R. M., Suarez, C. F., Heer, C., Álvarez, R., Iglesias, M., Balparda, J., Beruti, E., & Rubinstein, F. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.08.004 · Cited by 41 · see citing works

Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review

Hooper, A., Bacal, V., & Bedaiwy, M. A. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13761 · Cited by 28 · see citing works

Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis

Berman, A., Kenet, G., Lubetsky, A., Agmon‐Levin, N., Soffer, S., Barg, A. A., Levy‐Mendelovich, S., Cohen, O., Radinsky, L. W., Lalezari, S., et al. (2025) · RMD Open · doi:10.1136/rmdopen-2025-005825 · Cited by 12 · see citing works

Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

Carolis, S. D., Botta, A., Salvi, S., di Pasquo, E., Sordo, G. D., Garufi, C., Lanzone, A., & Carolis, M. P. D. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.010 · Cited by 43 · see citing works